Oral ganciclovir.
Schouten
J T
JT
D000284:Administration, Oral; D000998:Antiviral Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D017277:Drug Approval; D015774:Ganciclovir / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D015774:Ganciclovir